How intimate partner violence affects children s health theconversation.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theconversation.com Daily Mail and Mail on Sunday newspapers.
Share on Twitter
Achondroplasia, the most common form of dwarfism, is a rare genetic disorder that impacts bone growth, affecting around 1 in 25,000 children worldwide. People with achondroplasia can face a lifetime of health complications, including spinal column narrowing, spinal cord compression, and bowed legs.
The drug vosoritide - when injected once a day in young children - could reverse the effects of dwarfism and allow children to grow to average height.
Daisy’s son Casper has achondroplasia and was faced with the decision to be part of the vosoritide drug trial, which could change his expected height.
An average two-year-old grows about six centimetres a year, while a child with achondroplasia grows about four centimetres a year. When bone growth stops in early adulthood, the result is a dramatic reduction in height and proportions.
As Scientists Move Closer To Making Part Human, Part Animal Organisms, What Are The Concerns?
Share
Published 4 hours ago:
April 20, 2021 at 4:00 pm
To sign up for our daily newsletter covering the latest news, features and reviews, head HERE. For a running feed of all our stories, follow us on Twitter HERE. Or you can bookmark the Gizmodo Australia homepage to visit whenever you need a news fix.
The recent announcement that scientists have made human-monkey embryos and cultured them in the lab for two weeks made international headlines.
The technology to make animals that contain cells from other species has been available for decades and used extensively in research. These organisms are called “chimeras”.
 Daisy Broadway knows there will always be people against what her and her partner Justin Ebbels are doing for their son Casper. The Melbourne bub was enrolled in a controversial drug trial when he was months old and will receive daily injections until he s 18 and old enough to decide for himself if he wants to continue treatment. The world-first treatment, led by the Murdoch Children s Research Institute, is allowing those with achondroplasia to grow at the same rate as their peers and possibly avoid surgery. Daisy Broadway says theyâre doing what they think is best for Casperâs health.